ArTS Archivio della ricerca di Trieste

SALTON, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.553
AS - Asia 5.711
EU - Europa 5.550
SA - Sud America 687
Continente sconosciuto - Info sul continente non disponibili 500
AF - Africa 209
OC - Oceania 71
AN - Antartide 1
Totale 20.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.210
IT - Italia 2.079
SG - Singapore 1.861
CN - Cina 1.184
PL - Polonia 850
VN - Vietnam 668
HK - Hong Kong 548
BR - Brasile 520
DE - Germania 410
BD - Bangladesh 359
KR - Corea 350
SE - Svezia 334
GB - Regno Unito 316
FR - Francia 300
NL - Olanda 268
FI - Finlandia 217
RU - Federazione Russa 176
CA - Canada 169
IN - India 163
IE - Irlanda 107
MX - Messico 100
BG - Bulgaria 92
TR - Turchia 84
JP - Giappone 71
AT - Austria 67
MA - Marocco 63
AU - Australia 62
CH - Svizzera 59
ID - Indonesia 51
ES - Italia 50
AR - Argentina 45
IQ - Iraq 45
PK - Pakistan 36
PH - Filippine 35
SA - Arabia Saudita 35
UA - Ucraina 35
BE - Belgio 34
ZA - Sudafrica 33
CO - Colombia 32
TW - Taiwan 32
TH - Thailandia 25
EG - Egitto 24
EC - Ecuador 23
UZ - Uzbekistan 21
GR - Grecia 20
IR - Iran 20
SI - Slovenia 20
SN - Senegal 20
CL - Cile 19
VE - Venezuela 19
CZ - Repubblica Ceca 17
PT - Portogallo 17
CR - Costa Rica 14
IL - Israele 14
RO - Romania 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
MY - Malesia 12
TN - Tunisia 12
LT - Lituania 11
JO - Giordania 10
TT - Trinidad e Tobago 10
DK - Danimarca 9
OM - Oman 9
PA - Panama 9
KE - Kenya 8
LK - Sri Lanka 8
NZ - Nuova Zelanda 8
PY - Paraguay 8
AO - Angola 7
BY - Bielorussia 7
DZ - Algeria 7
ET - Etiopia 7
HN - Honduras 7
HU - Ungheria 7
JM - Giamaica 7
KZ - Kazakistan 7
UY - Uruguay 7
AL - Albania 6
BO - Bolivia 6
CI - Costa d'Avorio 6
NP - Nepal 6
GT - Guatemala 5
KG - Kirghizistan 5
LB - Libano 5
NG - Nigeria 5
NO - Norvegia 5
PE - Perù 5
NI - Nicaragua 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
YE - Yemen 4
BB - Barbados 3
DO - Repubblica Dominicana 3
EU - Europa 3
HR - Croazia 3
LU - Lussemburgo 3
LY - Libia 3
MN - Mongolia 3
RS - Serbia 3
Totale 19.731
Salva come PNG Salva come JPEG
Città #
Singapore 1.046
Ashburn 987
San Jose 792
Warsaw 731
Council Bluffs 526
Hong Kong 523
Chandler 441
Trieste 347
Hefei 336
Seoul 332
Beijing 277
Los Angeles 219
Ho Chi Minh City 196
Boardman 174
Columbus 170
Dallas 166
Hanoi 159
Fairfield 157
Milan 153
New York 141
London 140
Chicago 138
Santa Clara 127
Lauterbourg 112
Helsinki 102
Seattle 98
Frankfurt am Main 94
Houston 94
Princeton 94
The Dalles 94
Dublin 93
Zgierz 92
Sofia 89
Woodbridge 85
Rome 84
Wilmington 83
Munich 82
Moscow 80
Lappeenranta 69
Ann Arbor 66
Buffalo 61
São Paulo 60
Naples 59
Phoenix 59
Dong Ket 49
Montreal 48
Casablanca 46
Vienna 46
Redmond 45
Cambridge 44
Tokyo 43
Denver 42
Toronto 42
Nuremberg 41
Atlanta 40
Turku 39
Orem 37
Jacksonville 36
Amsterdam 34
Haiphong 34
Manchester 34
Sydney 32
Bern 31
Chennai 31
North Bergen 31
Udine 31
Boydton 30
Bologna 27
Redondo Beach 27
Da Nang 26
Mexico City 25
Shanghai 25
Guangzhou 24
Brussels 23
Düsseldorf 23
Paris 23
Redwood City 23
Bremen 22
Genoa 22
Mumbai 22
Turin 22
Berlin 21
Florence 21
Brooklyn 20
Dakar 20
Palermo 20
Rio de Janeiro 20
Treviso 20
Falls Church 19
Memphis 19
Wroclaw 19
Ankara 18
Campinas 18
San Francisco 18
Baghdad 17
Istanbul 17
Newark 17
Stockholm 17
Tashkent 17
Venice 17
Totale 11.603
Salva come PNG Salva come JPEG
Nome #
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 484
Alveolar Epithelial Type II Cells 453
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 441
Acute respiratory distress syndrome 432
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography 397
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation 382
Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis 339
Is early detection of late-onset Pompe disease a pneumologist’s affair? A lesson from an Italian screening study 282
Deciphering loop gain complexity: a primer for understanding a pathophysiological trait of obstructive sleep apnea patients 266
Imaging review of the lung parenchymal complications in patients with IPF 254
Comorbidities’ Effect on IPF: Pathogenesis and Management 230
Chronic Thromboembolic Pulmonary Hypertension: An Update 229
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 224
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 224
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 221
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 216
Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study 216
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 216
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 215
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 210
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 210
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia 209
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 208
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 208
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 207
C1-inhibitor is a novel prognostic factor in malignant pleural mesothelioma and in serous ovarian carcinoma 204
Emergency Laser Treatment of a Tracheobronchial Carcinoid during ECMO 202
Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon 202
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 201
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 201
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 200
184 Complement score: A novel prognostic tool in malignant pleural mesothelioma? 198
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 195
The Treatment of Lung Involvement in Systemic Sclerosis 193
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 191
Low arousal threshold: a common pathophysiological trait in patients with obstructive sleep apnea syndrome and asthma 189
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 186
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 182
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 182
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 181
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 177
Complement component C1q can predict patients’ response to cisplatin depending on tumour type: A step towards personalized medicine? 177
Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker 176
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 176
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 171
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 171
Il supporto decisionale nei processi di acquisto dei broncoscopi monouso 169
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings 168
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis 168
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 168
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 163
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier 159
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease 156
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 156
Calcified Lung Nodules: A Diagnostic Challenge in Clinical Daily Practice 155
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 154
Low Arousal Threshold Estimation Predicts Failure of Mandibular Advancement Devices in Obstructive Sleep Apnea Syndrome 153
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 152
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis 150
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 149
Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support 149
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure? 148
Host-Based Treatments for Severe COVID-19 146
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 146
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 146
Interstitial lung disease at high resolution ct after SARS‐COV‐2‐related acute respiratory distress syndrome according to pulmonary segmental anatomy 146
Caution When Comparing the Impact of Corticosteroids in COVID-19 145
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 144
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment 143
Flt1 produced by lung endothelial cells impairs ATII cell transdifferentiation and repair in pulmonary fibrosis 141
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 140
Nailfold Video-Capillaroscopy in Sarcoidosis: New Perspectives and Challenges 140
Advances in Diagnostics and Management of Respiratory System Diseases 139
Pulmonary fibrosis: one manifestation, various diseases 138
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 138
Autoantibodies in sarcoidosis: innocent bystander or promising biomarker for organ involvement? 135
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant 135
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity 135
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated 132
OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS). WHAT’S NEW? 131
Valutazione dei fattori di rischio di embolia polmonare nei pazienti affetti da sarcoidosi 130
MicroRNA-200 revertono il fenotipo di pneumociti tipo II primari da fibrosi polmonare idiopatica 130
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 129
Biomarkers in Systemic Sclerosis: An Overview 129
Oscillometry Longitudinal Data on COVID-19 Acute Respiratory Syndrome Treated with Non-Invasive Respiratory Support 128
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 125
Analyzing Sarcoidosis via Nailfold Capillaroscopy: Microvascular Insights 124
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 118
Monitoraggio degli scambi gassosi e dell’equilibrio acido-base durante ventilazione meccanica 113
Exploring sarcoidosis via nailfold capillaroscopy: A window into the disease’s microvascular landscape 113
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 113
Pulmonary Fibrosis: one manifestation, various diseases 112
CT Imaging Features of Pulmonary Sarcoidosis: Typical and Atypical Radiological Features and Their Differential Diagnosis 112
Monitoring lung mechanics by oscillometry in COVID 19 ARDS receiving non-invasive ventilation: a pilot study 107
Obstructive Sleep Apnea Syndrome in women: gender in sleep respiratory medicine is a first step towards personalized medicine 105
The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis 105
Walking the fine line between OSA and aging 104
Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19 102
Evaluation of Nailfold Capillaroscopy as a Novel Tool in the Assessment of Eosinophilic Granulomatosis with Polyangiitis. 100
Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series Study 100
Totale 18.264
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.266
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022791 0 0 69 72 58 52 100 23 126 60 56 175
2022/20231.560 135 204 154 178 115 198 56 135 189 41 108 47
2023/20241.592 93 82 125 112 139 152 315 213 49 86 139 87
2024/20253.342 79 185 236 269 265 255 197 195 407 459 391 404
2025/20269.756 825 526 675 976 747 747 1.319 397 1.055 1.219 770 500
2026/20271.365 475 572 318 0 0 0 0 0 0 0 0 0
Totale 20.282